Triparna Sen/X
May 8, 2025, 14:55
Triparna Sen about the future of small cell lung cancer research at 2025 LiveLung SCLC Summit
Triparna Sen, Director of the Lung Cancer PDX Platform at the Icahn School of Medicine at Mount Sinai, shared a post on X by LiveLung, adding:
“From basic science at The American Association of Immunologists (AAI), IMMUNOLOGY 2025, to conversations with patients and caregivers.
Excited to return for the LiveLung 2025 Small Cell Summit on May 6–7 in Raleigh, NC, where I will do a fireside chat on the latest research and treatment advances in small cell lung cancer (SCLC).
This transformative event brings together leading experts, patients, and care partners to share the latest on clinical trials, wellness strategies, and advocacy efforts-all to improve outcomes in SCLC.It was amazing to join the 2024 SCLC summit-an unforgettable experience filled with meaningful conversations, shared stories, and connections with patients and caregivers.
Grateful to the organizers and looking forward to continuing to grow with this incredible community.”
Quoting LiveLung‘s post:
“Hear from Triparna Sen at the SCLC Summit 25!
Dr. Sen, PhD, MS, is an Associate Professor of Oncological Sciences and Director of the Lung Cancer PDX Platform at Icahn School of Medicine at Mount Sinai, New York.
Follow updates on our social media and join the conversation using #SCLCSummit25.”
More posts featuring Triparna Sen and on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 29, 2025, 22:38
May 29, 2025, 22:26